Reappraising the formation of Jaffé's base: Studies of the treatment of imidazolidine-2-thione with mild oxidising agents

被引:0
|
作者
Thanyasirikul, Yupa [1 ,2 ]
Pakawatchai, Chaveng [1 ,2 ]
Cole, Marcus L. [3 ]
Junk, Peter C. [1 ,2 ,3 ]
Skelton, Brian W. [2 ]
White, Allan H. [2 ]
机构
[1] Department of Chemistry, Prince of Songkla University, Hat Yai 90112, Thailand
[2] Chemistry, University of Western Australia, Crawley, WA 6009, Australia
[3] School of Chemistry, Monash University, Victoria, Vic. 3800, Australia
来源
Org. Biomol. Chem. | / 18卷 / 3217-3222期
关键词
Compendex;
D O I
暂无
中图分类号
学科分类号
摘要
Acetone - Byproducts - Condensation - Crystallization - Nuclear magnetic resonance spectroscopy - Potassium compounds - X ray diffraction analysis
引用
收藏
相关论文
共 30 条
  • [21] Synthesis, crystal structure, and antimicrobial studies of trans-[Pd(PPh3)2(imidazolidine-2-thione)2]Cl2 • 3.5H2O
    Ahmad, S.
    Rueffer, T.
    Lang, H.
    Nadeem, S.
    Tirmizi, S. A.
    Saleem, M.
    Anwar, A.
    RUSSIAN JOURNAL OF COORDINATION CHEMISTRY, 2010, 36 (07) : 520 - 524
  • [22] Synthesis, crystal structure, and antimicrobial studies of trans-[Pd(PPh3)2(imidazolidine-2-thione)2]Cl2 · 3.5H2O
    S. Ahmad
    T. Rüffer
    H. Lang
    S. Nadeem
    S. A. Tirmizi
    M. Saleem
    A. Anwar
    Russian Journal of Coordination Chemistry, 2010, 36 : 520 - 524
  • [23] Crystal Structure of [Pd(Imt)4]Cl2 and DFT Studies of [Pd(Imt)4]Cl2 and [Pd(Imt)2(CN)2] (Imt = Imidazolidine-2-Thione)
    Sadaf, H.
    Zierkiewicz, W.
    Michalczyk, M.
    Ahmad, S.
    Imtiaz-ud-Din
    Tahir, M. Nawaz
    Isab, A. A.
    Al-Arfaj, A. R.
    Nadeem, S.
    RUSSIAN JOURNAL OF COORDINATION CHEMISTRY, 2021, 47 (01) : 81 - 87
  • [24] Crystal Structure of [Pd(Imt)4]Cl2 and DFT Studies of [Pd(Imt)4]Cl2 and [Pd(Imt)2(CN)2] (Imt = Imidazolidine-2-Thione)
    H. Sadaf
    W. Zierkiewicz
    M. Michalczyk
    S. Ahmad
    M. Nawaz Imtiaz-ud-Din
    A. A. Tahir
    A. R. Isab
    S. Al-Arfaj
    Russian Journal of Coordination Chemistry, 2021, 47 : 81 - 87
  • [26] Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents
    Hunt, MJ
    Morton, AJ
    EXPERIMENTAL BRAIN RESEARCH, 2005, 166 (02) : 220 - 229
  • [27] Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington’s disease is not improved by treatment with hypoglycaemic agents
    Mark J. Hunt
    A. Jennifer Morton
    Experimental Brain Research, 2005, 166 : 220 - 229
  • [28] Design, Synthesis, Biological Evaluation and Docking Studies of 2-hydroxy-4-benzyloxy Chalcone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease
    Li, Wei
    Huang, Jing
    Chen, Zhixin
    Zhang, Dan
    He, Lin
    Guo, Yan
    Zhong, Lei
    Yang, Chenwu
    Yang, Chunyan
    Zeng, Mei
    Zhu, Jiang
    Cao, Zhongcheng
    CURRENT MEDICINAL CHEMISTRY, 2025,
  • [29] 2D-QSAR and molecular docking studies of carbamate derivatives to discover novel potent anti-butyrylcholinesterase agents for Alzheimer's disease treatment
    Nour, Hassan
    Abchir, Oussama
    Belaidi, Salah
    Qais, Faizan Abul
    Chtita, Samir
    Belaaouad, Said
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2022, 43 (02) : 277 - 292
  • [30] Allosteric antagonists of sigma-2/PGRMC1 complex: Brain penetrant orally active amyloid oligomer-displacing agents for the treatment and prevention of mild cognitive impairment and Alzheimer's disease
    Rishton, Gilbert
    Look, Gary
    Ni, Zhi-Jie
    Zhang, Jason
    Huang, Yaodong
    Wu, Xiaodong
    Izzo, Nicholas
    Mozzoni, Kelsie
    Silky, Colleen
    Rehak, Courtney
    Yurko, Raymond
    Catalano, Susan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254